Overview

Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19

Status:
Completed
Trial end date:
2021-04-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if Quercetin Phytosome is beneficial for the treatment of COVID-19.
Phase:
Phase 3
Details
Lead Sponsor:
Liaquat University of Medical & Health Sciences
Collaborators:
Dow University of Health Sciences
University of Milano Bicocca
University of Oxford
University of Pavia
Treatments:
Quercetin